Related content

Targeting the EGF/VEGF-R system by tyrosine-kinase inhibitors—a novel antiproliferative/antiangiogenic strategy in thyroid cancer

By Hoffmann S.   Gläser S.   Wunderlich A.   Lingelbach S.   Dietrich C.   Burchert A.   Müller H.   Rothmund M.   Zielke A.  

Langenbeck's Archives of Surgery, Vol. 391, Iss. 6, 2006-11 ,pp. : 589-596

Springer Publishing Company

Access to resources Recommend Favorite

The efficacy of tyrosine kinase inhibitors on human pancreatic cancer cell lines 1

By Farivar R.S.   Gardner-Thorpe J.   Ito H.   Arshad H.   Zinner M.J.   Ashley S.W.   Whang E.E.  

Journal of Surgical Research, Vol. 115, Iss. 2, 2003-12 ,pp. : 219-225

Elsevier

Access to resources Recommend Favorite

In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer

By Beck T.P.   Kirsh E.J.   Chmura S.J.   Kovar D.A.   Chung T.   Rinker-Schaeffer C.W.   Stadler W.M.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 573-577

Elsevier

Access to resources Recommend Favorite

Odontogenic Ameloblast Associated Protein as a Novel Biomarker for Human Breast Cancer

By Siddiqui Sabina   Bruker C. Todd   Kestler Daniel P.   Foster James S.   Gray Keith D.   Solomon Alan   Bell John L.  

The American Surgeon, Vol. 75, Iss. 9, 2009-09 ,pp. : 769-775

Southeastern Surgical Congress

Access to resources Recommend Favorite

Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: a novel therapy in prostate cancer

By Balaji K.C.   Koul H.   Mitra S.   Maramag C.   Reddy P.   Menon M.   Malhotra R.K.   Laxmanan S.  

Urology, Vol. 50, Iss. 6, 1997-12 ,pp. : 1007-1015

Elsevier

Access to resources Recommend Favorite